{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:40:00Z","timestamp":1792658400399,"version":"4.5.0"},"reference-count":53,"publisher":"e-Century Publishing Corporation","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Exp Pathol"],"DOI":"10.62347\/buyc8564","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:07:32Z","timestamp":1785226052000},"page":"324-339","source":"Crossref","is-referenced-by-count":0,"title":["PDGFRA mediates the PI3K\/AKT signaling pathway to regulate the growth and phenotype of GCTB tumor cells"],"prefix":"10.62347","volume":"19","author":[{"given":"Tiantian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanda","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongguang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Aoude A, Nikomarov D, Perera JR, Ibe IK, Griffin AM, Tsoi KM, Ferguson PC and Wunder JS. Giant cell tumour of bone. Bone Joint J 2023; 105-B: 559-567.","DOI":"10.1302\/0301-620X.105B5.BJJ-2022-1231.R1"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00432-008-0370-x","article-title":"Giant cell tumor of bone: treatment and outcome of 214 cases","volume":"134","author":"Balke","year":"2008","unstructured":"Balke M, Schremper L, Gebert C, Ahrens H, Streitbuerger A, Koehler G, Hardes J and Gosheger G. Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol 2008; 134: 969-978.","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11912-021-01047-5","article-title":"Giant cell tumor of bone: an update","volume":"23","author":"Basu Mallick","year":"2021","unstructured":"Basu Mallick A and Chawla SP. Giant cell tumor of bone: an update. Curr Oncol Rep 2021; 23: 51.","journal-title":"Curr Oncol Rep"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Jha Y and Chaudhary K. Giant cell tumour of bone: a comprehensive review of pathogenesis, diagnosis, and treatment. Cureus 2023; 15: e46945.","DOI":"10.7759\/cureus.46945"},{"key":"ref4","unstructured":"Brecher ME, Franklin WA and Simon MA. Immunohistochemical study of mononuclear phagocyte antigens in giant cell tumor of bone. Am J Pathol 1986; 125: 252-257."},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Szendröi M. Giant-cell tumour of bone. J Bone Joint Surg Br 2004; 86: 5-12.","DOI":"10.1302\/0301-620X.86B1.14053"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3928\/01477447-20140124-08","article-title":"Giant cell tumor of bone","volume":"37","author":"Amanatullah","year":"2014","unstructured":"Amanatullah DF, Clark TR, Lopez MJ, Borys D and Tamurian RM. Giant cell tumor of bone. Orthopedics 2014; 37: 112-120.","journal-title":"Orthopedics"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s004320100234","article-title":"The nature of giant cell tumor of bone","volume":"127","author":"W&#xFC","year":"2001","unstructured":"Wülling M, Engels C, Jesse N, Werner M, Delling G and Kaiser E. The nature of giant cell tumor of bone. J Cancer Res Clin Oncol 2001; 127: 467-474.","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jcot.2015.09.006","article-title":"Histopathological, immunohistochemical, and image analytic parameters characterizing the stromal component in primary and recurrent giant cell tumor of bone","volume":"7","author":"Saxena","year":"2016","unstructured":"Saxena CC, Safaya R, Kawatra Madan N, Khan SA and Iyer VK. Histopathological, immunohistochemical, and image analytic parameters characterizing the stromal component in primary and recurrent giant cell tumor of bone. J Clin Orthop Trauma 2016; 7: 109-114.","journal-title":"J Clin Orthop Trauma"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/jemt.23976","article-title":"Stromal cells of giant cell tumor of bone show primary cilia in giant cell tumor of bone","volume":"85","author":"Castiella","year":"2022","unstructured":"Castiella T, Iruzubieta P, Monleón E, Cardiel MJ, Gómez-Vallejo J, Monzón M and Junquera MC. Stromal cells of giant cell tumor of bone show primary cilia in giant cell tumor of bone. Microsc Res Tech 2022; 85: 1065-1074.","journal-title":"Microsc Res Tech"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1126\/science.959840","article-title":"The clonal evolution of tumor cell populations","volume":"194","author":"Nowell","year":"1976","unstructured":"Nowell PC. The clonal evolution of tumor cell populations. Science 1976; 194: 23-28.","journal-title":"Science"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/jcp.50.8.664","article-title":"Molecular analysis of clonality in Kaposi’s sarcoma","volume":"50","author":"Delabesse","year":"1997","unstructured":"Delabesse E, Oksenhendler E, Lebbé C, Vérola O, Varet B and Turhan AG. Molecular analysis of clonality in Kaposi’s sarcoma. J Clin Pathol 1997; 50: 664-668.","journal-title":"J Clin Pathol"},{"key":"ref12","unstructured":"LYON MF. Sex chromatin and gene action in the mammalian X-chromosome. Am J Hum Genet 1962; 14: 135-148."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"LD","year":"2013","unstructured":"Moore LD, Le T and Fan G. DNA methylation and its basic function. Neuropsychopharmacology 2013; 38: 23-38.","journal-title":"Neuropsychopharmacology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ceb.2017.01.007","article-title":"X chromosome inactivation: silencing, topology and reactivation","volume":"46","author":"Robert Finestra","year":"2017","unstructured":"Robert Finestra T and Gribnau J. X chromosome inactivation: silencing, topology and reactivation. Curr Opin Cell Biol 2017; 46: 54-61.","journal-title":"Curr Opin Cell Biol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1007\/s10238-023-01079-0","article-title":"Denosumab for giant cell tumors of bone from 2010 to 2022: a bibliometric analysis","volume":"23","author":"Tan","year":"2023","unstructured":"Tan X, Zhang Y, Wei D, Yang Y and Xiang F. Denosumab for giant cell tumors of bone from 2010 to 2022: a bibliometric analysis. Clin Exp Med 2023; 23: 3053-3075.","journal-title":"Clin Exp Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4055\/cios.2019.11.3.352","article-title":"Evaluation of local recurrence in giant-cell tumor of bone treated by neoadjuvant denosumab","volume":"11","author":"Chinder","year":"2019","unstructured":"Chinder PS, Hindiskere S, Doddarangappa S and Pal U. Evaluation of local recurrence in giant-cell tumor of bone treated by neoadjuvant denosumab. Clin Orthop Surg 2019; 11: 352-360.","journal-title":"Clin Orthop Surg"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jos.2020.11.005","article-title":"Clinical and pathological analysis of giant cell tumor of bone with denosumab treatment and local recurrence","volume":"27","author":"Hayashida","year":"2022","unstructured":"Hayashida K, Kawabata Y, Kato I, Kamiishi T, Matsuo K, Takeyama M and Inaba Y. Clinical and pathological analysis of giant cell tumor of bone with denosumab treatment and local recurrence. J Orthop Sci 2022; 27: 215-221.","journal-title":"J Orthop Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jhsa.2023.02.013","article-title":"The role of denosumab in the treatment of primary tumors of bone","volume":"48","author":"Wessel","year":"2023","unstructured":"Wessel LE, Strike SA, Singh A, Bernthal NM and Athanasian EA. The role of denosumab in the treatment of primary tumors of bone. J Hand Surg Am 2023; 48: 923-930.","journal-title":"J Hand Surg Am"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/jmcb\/mjq026","article-title":"Partial reversal of the methylation pattern of the X-linked gene HUMARA during hematopoietic differentiation of human embryonic stem cells","volume":"2","author":"Mitjavila-Garcia MT","year":"2010","unstructured":"Mitjavila-Garcia MT, Bonnet ML, Yates F, Haddad R, Oudrhiri N, Féraud O, Magniez A, Makhlouf M, Vallot C, Rougeulle C, Bennaceur-Griscelli A and Turhan AG. Partial reversal of the methylation pattern of the X-linked gene HUMARA during hematopoietic differentiation of human embryonic stem cells. J Mol Cell Biol 2010; 2: 291-298.","journal-title":"J Mol Cell Biol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1056\/NEJM199704033361403","article-title":"Monoclonal origin of multicentric Kaposi’s sarcoma lesions","volume":"336","author":"Rabkin","year":"1997","unstructured":"Rabkin CS, Janz S, Lash A, Coleman AE, Musaba E, Liotta L, Biggar RJ and Zhuang Z. Monoclonal origin of multicentric Kaposi’s sarcoma lesions. N Engl J Med 1997; 336: 988-993.","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.humpath.2015.09.032","article-title":"Clonality assessment of adenomatoid tumor supports its neoplastic nature","volume":"48","author":"Wang","year":"2016","unstructured":"Wang W, Zhu H, Wang J, Wang S, Wang D, Zhao J and Zhu H. Clonality assessment of adenomatoid tumor supports its neoplastic nature. Hum Pathol 2016; 48: 88-94.","journal-title":"Hum Pathol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1530\/eje.0.1460027","article-title":"Clonal origin of non-medullary thyroid tumours assessed by non-random X-chromosome inactivation","volume":"146","author":"Moniz","year":"2002","unstructured":"Moniz S, Catarino AL, Marques AR, Cavaco B, Sobrinho L and Leite V. Clonal origin of non-medullary thyroid tumours assessed by non-random X-chromosome inactivation. Eur J Endocrinol 2002; 146: 27-33.","journal-title":"Eur J Endocrinol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"715552","DOI":"10.3389\/fonc.2021.715552","article-title":"Single-cell RNA sequencing reveals the migration of osteoclasts in giant cell tumor of bone","volume":"11","author":"Feng","year":"2021","unstructured":"Feng W, He M, Jiang X, Liu H, Xie T, Qin Z, Huang Q, Liao S, Lin C, He J, Xu J, Ma J, Liu Y and Wei Q. Single-cell RNA sequencing reveals the migration of osteoclasts in giant cell tumor of bone. Front Oncol 2021; 11: 715552.","journal-title":"Front Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3892\/ol.2020.11947","article-title":"p62 overexpression promotes neoplastic stromal cell proliferation and is associated with the recurrence of giant cell tumor of bone","volume":"20","author":"Liu","year":"2020","unstructured":"Liu S, Ye F, Li D, He C, He H and Zhang J. p62 overexpression promotes neoplastic stromal cell proliferation and is associated with the recurrence of giant cell tumor of bone. Oncol Lett 2020; 20: 86.","journal-title":"Oncol Lett"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"6471","DOI":"10.7150\/thno.96723","article-title":"Mitochondrial transfer balances cell redox, energy and metabolic homeostasis in the osteoarthritic chondrocyte preserving cartilage integrity","volume":"14","author":"AC","year":"2024","unstructured":"Court AC, Vega-Letter AM, Parra-Crisóstomo E, Velarde F, García C, Ortloff A, Vernal R, Pradenas C, Luz-Crawford P, Khoury M and Figueroa FE. Mitochondrial transfer balances cell redox, energy and metabolic homeostasis in the osteoarthritic chondrocyte preserving cartilage integrity. Theranostics 2024; 14: 6471-6486.","journal-title":"Theranostics"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2174\/0115680096265253231022185008","article-title":"Denosumab induces neoplastic stromal cell apoptosis via p62 downregulation dependent on autophagy pathway in giant cell tumour of bone","volume":"24","author":"Chen","year":"2024","unstructured":"Chen X, Ye F, He H, Chen G, Chen Z, Ye E, He B, Yang Y and Zhang J. Denosumab induces neoplastic stromal cell apoptosis via p62 downregulation dependent on autophagy pathway in giant cell tumour of bone. Curr Cancer Drug Targets 2024; 24: 565-578.","journal-title":"Curr Cancer Drug Targets"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Schubert A, Brockmeyer P, Kauffmann P, Wiegel J, Lautenbacher F, Miosge N and Schminke B. Alterations of bone proteins in medication-related osteonecrosis of the jaw. Eur J Oral Sci 2025; 133: e70003.","DOI":"10.1111\/eos.70003"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.3390\/ijms20071694","article-title":"Regulation of proliferation, differentiation and functions of osteoblasts by runx2","volume":"20","author":"Komori","year":"2019","unstructured":"Komori T. Regulation of proliferation, differentiation and functions of osteoblasts by runx2. Int J Mol Sci 2019; 20: 1694.","journal-title":"Int J Mol Sci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"8987","DOI":"10.1016\/S0021-9258(18)31541-2","article-title":"Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation","volume":"266","author":"Kelly","year":"1991","unstructured":"Kelly JD, Haldeman BA, Grant FJ, Murray MJ, Seifert RA, Bowen-Pope DF, Cooper JA and Kazlauskas A. Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation. J Biol Chem 1991; 266: 8987-8992.","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Evans EK, Gardino AK, Kim JL, Hodous BL, Shutes A, Davis A, Zhu XJ, Schmidt-Kittler O, Wilson D, Wilson K, DiPietro L, Zhang Y, Brooijmans N, LaBranche TP, Wozniak A, Gebreyohannes YK, Schöffski P, Heinrich MC, DeAngelo DJ, Miller S, Wolf B, Kohl N, Guzi T, Lydon N, Boral A and Lengauer C. A precision therapy against cancers driven by KIT\/PDGFRA mutations. Sci Transl Med 2017; 9: eaao1690.","DOI":"10.1126\/scitranslmed.aao1690"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.3390\/cancers12102972","article-title":"Therapeutic potential of PI3K\/AKT\/mTOR pathway in gastrointestinal stromal tumors: rationale and progress","volume":"12","author":"Duan","year":"2020","unstructured":"Duan Y, Haybaeck J and Yang Z. Therapeutic potential of PI3K\/AKT\/mTOR pathway in gastrointestinal stromal tumors: rationale and progress. Cancers (Basel) 2020; 12: 2972.","journal-title":"Cancers (Basel)"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1746-1596-5-62","article-title":"A case of recurrent giant cell tumor of bone with malignant transformation and benign pulmonary metastases","volume":"5","author":"Miller","year":"2010","unstructured":"Miller IJ, Blank A, Yin SM, McNickle A, Gray R and Gitelis S. A case of recurrent giant cell tumor of bone with malignant transformation and benign pulmonary metastases. Diagn Pathol 2010; 5: 62.","journal-title":"Diagn Pathol"},{"key":"ref33","unstructured":"Quatman CE, Alexander JH, Wakely PE Jr and Mayerson JL. Transformation of benign giant cell tumor of bone into epithelioid angiosarcoma. Am J Orthop (Belle Mead NJ) 2017; 46: E463-E467."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1440-1827.1998.tb03918.x","article-title":"Giant cell tumor of bone: an immunohistochemical comparative study","volume":"48","author":"Masui","year":"1998","unstructured":"Masui F, Ushigome S and Fujii K. Giant cell tumor of bone: an immunohistochemical comparative study. Pathol Int 1998; 48: 355-361.","journal-title":"Pathol Int"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0736-0266(01)00117-6","article-title":"Clonality studies in giant cell tumor of bone","volume":"20","author":"HS","year":"2002","unstructured":"Schwartz HS, Eskew JD and Butler MG. Clonality studies in giant cell tumor of bone. J Orthop Res 2002; 20: 387-390.","journal-title":"J Orthop Res"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"118","DOI":"10.5435\/JAAOS-21-02-118","article-title":"Giant cell tumor of bone","volume":"21","author":"Raskin","year":"2013","unstructured":"Raskin KA, Schwab JH, Mankin HJ, Springfield DS and Hornicek FJ. Giant cell tumor of bone. J Am Acad Orthop Surg 2013; 21: 118-126.","journal-title":"J Am Acad Orthop Surg"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/jcp.42.4.414","article-title":"KP1: a new monoclonal antibody that detects a monocyte\/macrophage associated antigen in routinely processed tissue sections","volume":"42","author":"Pulford","year":"1989","unstructured":"Pulford KA, Rigney EM, Micklem KJ, Jones M, Stross WP, Gatter KC and Mason DY. KP1: a new monoclonal antibody that detects a monocyte\/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 1989; 42: 414-421.","journal-title":"J Clin Pathol"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Wülling M, Delling G and Kaiser E. The origin of the neoplastic stromal cell in giant cell tumor of bone. Hum Pathol 2003; 34: 983-993.","DOI":"10.1053\/S0046-8177(03)00413-1"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/BLO.0b013e31804856a1","article-title":"Properties of the stromal cell in giant cell tumor of bone","volume":"459","author":"Ghert","year":"2007","unstructured":"Ghert M, Simunovic N, Cowan RW, Colterjohn N and Singh G. Properties of the stromal cell in giant cell tumor of bone. Clin Orthop Relat Res 2007; 459: 8-13.","journal-title":"Clin Orthop Relat Res"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/path.1711470302","article-title":"An immunohistological study of giant-cell tumour of bone: evidence for an osteoclast origin of the giant cells","volume":"147","author":"Athanasou","year":"1985","unstructured":"Athanasou NA, Bliss E, Gatter KC, Heryet A, Woods CG and McGee JO. An immunohistological study of giant-cell tumour of bone: evidence for an osteoclast origin of the giant cells. J Pathol 1985; 147: 153-158.","journal-title":"J Pathol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0169-6009(92)90820-4","article-title":"Phenotypic characterisation of mononuclear and multinucleated cells of giant cell tumour of bone","volume":"16","author":"Joyner","year":"1992","unstructured":"Joyner CJ, Quinn JM, Triffitt JT, Owen ME and Athanasou NA. Phenotypic characterisation of mononuclear and multinucleated cells of giant cell tumour of bone. Bone Miner 1992; 16: 37-48.","journal-title":"Bone Miner"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"0050","DOI":"10.34133\/bdr.0050","article-title":"Unlocking the potential of collagenases: structures, functions, and emerging therapeutic horizons","volume":"6","author":"Wang","year":"2024","unstructured":"Wang ZZ, Wang K, Xu LF, Su C, Gong JS, Shi JS, Ma XD, Xie N and Qian JY. Unlocking the potential of collagenases: structures, functions, and emerging therapeutic horizons. Biodes Res 2024; 6: 0050.","journal-title":"Biodes Res"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1021\/bi00377a004","article-title":"Limited proteolysis of type I collagen at hyperreactive sites by class I and II Clostridium histolyticum collagenases: complementary digestion patterns","volume":"26","author":"MF","year":"1987","unstructured":"French MF, Mookhtiar KA and Van Wart HE. Limited proteolysis of type I collagen at hyperreactive sites by class I and II Clostridium histolyticum collagenases: complementary digestion patterns. Biochemistry 1987; 26: 681-687.","journal-title":"Biochemistry"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-981-15-8104-5_4","article-title":"Histone mutations and bone cancers","volume":"1283","author":"Taylor","year":"2021","unstructured":"Taylor EL and Westendorf JJ. Histone mutations and bone cancers. Adv Exp Med Biol 2021; 1283: 53-62.","journal-title":"Adv Exp Med Biol"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Lüke J, von Baer A, Schreiber J, Lübbehüsen C, Breining T, Mellert K, Marienfeld R, Schultheiss M, Möller P and Barth TFE. H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant. Histopathology 2017; 71: 125-133.","DOI":"10.1111\/his.13190"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/03008207.2013.848202","article-title":"Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone","volume":"54","author":"Lau","year":"2013","unstructured":"Lau CP, Huang L, Wong KC and Kumta SM. Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone. Connect Tissue Res 2013; 54: 439-449.","journal-title":"Connect Tissue Res"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Mak IW, Evaniew N, Popovic S, Tozer R and Ghert M. A translational study of the neoplastic cells of giant cell tumor of bone following neoadjuvant denosumab. J Bone Joint Surg Am 2014; 96: e127.","DOI":"10.2106\/JBJS.M.01332"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.2217\/fon-2020-0348","article-title":"Avapritinib in the treatment of PDGFRA exon 18 mutated gastrointestinal stromal tumors","volume":"16","author":"Smrke","year":"2020","unstructured":"Smrke A, Gennatas S, Huang P and Jones RL. Avapritinib in the treatment of PDGFRA exon 18 mutated gastrointestinal stromal tumors. Future Oncol 2020; 16: 1639-1646.","journal-title":"Future Oncol"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Le N, Chen J, Ekert PG, Brown LM and Manoharan N. PDGFRA in paediatric high-grade glioma - target or distraction? Neoplasia 2025; 69: 101231.","DOI":"10.1016\/j.neo.2025.101231"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.3390\/cancers13143543","article-title":"New target for precision medicine treatment of giant-cell tumor of bone: sunitinib is effective in the treatment of neoplastic stromal cells with activated PDGFRβ signaling","volume":"13","author":"Mahdal","year":"2021","unstructured":"Mahdal M, Neradil J, Mudry P, Paukovcekova S, Staniczkova Zambo I, Urban J, Macsek P, Pazourek L, Tomas T and Veselska R. New target for precision medicine treatment of giant-cell tumor of bone: sunitinib is effective in the treatment of neoplastic stromal cells with activated PDGFRβ signaling. Cancers (Basel) 2021; 13: 3543.","journal-title":"Cancers (Basel)"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.3390\/cancers13163949","article-title":"The pathogenic role of PI3K\/AKT pathway in cancer onset and drug resistance: an updated review","volume":"13","author":"Rascio","year":"2021","unstructured":"Rascio F, Spadaccino F, Rocchetti MT, Castellano G, Stallone G, Netti GS and Ranieri E. The pathogenic role of PI3K\/AKT pathway in cancer onset and drug resistance: an updated review. Cancers (Basel) 2021; 13: 3949.","journal-title":"Cancers (Basel)"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cca.2014.12.041","article-title":"PI3K\/Akt signaling in osteosarcoma","volume":"444","author":"Zhang","year":"2015","unstructured":"Zhang J, Yu XH, Yan YG, Wang C and Wang WJ. PI3K\/Akt signaling in osteosarcoma. Clin Chim Acta 2015; 444: 182-192.","journal-title":"Clin Chim Acta"}],"container-title":["International Journal of Clinical and Experimental Pathology"],"original-title":[],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:00:55Z","timestamp":1792656055000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ijcep\/19\/7\/ijcep0169998.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":53,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.62347\/buyc8564","relation":{},"ISSN":["1936-2625"],"issn-type":[{"value":"1936-2625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}